Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Acta Oncologica (Stockholm, Sweden)|November 14, 2017
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) studyElisabet Hjerpe, Christian Staf, Pernilla Dahm-Kähler, et al.
Acta Oncologica (Stockholm, Sweden)|November 5, 2021
The wait time to primary surgery in endometrial cancer - impact on survival and predictive factors: a population-based SweGCG studyJanusz Marcickiewicz, Elisabeth Åvall-Lundqvist, Erik Carl Viktor Holmberg, et al.
Gynecologic Oncology|September 4, 2019
Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group StudyMaria Bjurberg, Erik Holmberg, Christer Borgfeldt, et al.
BMC Cancer|June 3, 2021
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery - a Swedish Gynecologic Cancer Group (SweGCG) studyChrister Borgfeldt, Erik Holmberg, Janusz Marcickiewicz, et al.
Gynecologic Oncology|September 29, 2020
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG studyKristina Hellman, Erik Holmberg, Maria Bjurberg, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 15, 2021
Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer-A Swedish Gynecologic Cancer Group (SweGCG) studyBjörg Jónsdóttir, Janusz Marcickiewicz, Christer Borgfeldt, et al.
Gynecologic Oncology|February 14, 2021
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG studyPernilla Dahm-Kähler, Erik Holmberg, Mikael Holtenman, et al.
Acta Oncologica (Stockholm, Sweden)|August 3, 2019
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) studyKarin Stålberg, Maria Bjurberg, Christer Borgfeldt, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2010
Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonistsPradip K Sasmal, Sanjita Sasmal, P Tirumala Rao, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2012
Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonistsSanjita Sasmal, Gade Balaji, Hariprasada R Kanna Reddy, et al.
Pageof 5